StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$26.42−1.33 (-4.79%)

Close on Nov 18, 2026Market cap $1.72BP/E –Yield –

Zenas BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zenas BioPharma's price to sales ratio was 105.3× on Apr 30, 2026, against 96.8× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026105.3×+3.1
2025Dec 31, 2025102.2×–

More Zenas BioPharma figures

See a number that looks wrong?